Perspective Therapeutics Shares Owned By Institutions vs. Current Valuation
| CATX Stock | 4.12 0.28 6.36% |
For Perspective Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Perspective Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Perspective Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Perspective Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Perspective Therapeutics over time as well as its relative position and ranking within its peers.
Perspective |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Perspective Therapeutics. If investors know Perspective will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Perspective Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share 0.029 | Quarterly Revenue Growth 0.337 | Return On Assets (0.14) | Return On Equity (0.27) |
The market value of Perspective Therapeutics is measured differently than its book value, which is the value of Perspective that is recorded on the company's balance sheet. Investors also form their own opinion of Perspective Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Perspective Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Perspective Therapeutics' market value can be influenced by many factors that don't directly affect Perspective Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Perspective Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Perspective Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Perspective Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Perspective Therapeutics Current Valuation vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Perspective Therapeutics's current stock value. Our valuation model uses many indicators to compare Perspective Therapeutics value to that of its competitors to determine the firm's financial worth. Perspective Therapeutics is rated below average in shares owned by institutions category among its peers. It is rated below average in current valuation category among its peers reporting about 182,772 of Current Valuation per Shares Owned By Institutions. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Perspective Therapeutics' earnings, one of the primary drivers of an investment's value.Perspective Current Valuation vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Perspective Therapeutics |
| = | 81.42 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Perspective Therapeutics |
| = | 14.88 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Perspective Current Valuation vs Competition
Perspective Therapeutics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 7.85 Billion. Perspective Therapeutics adds roughly 14.88 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Perspective Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Perspective Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Perspective Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Perspective Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Perspective Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -6.9 M | -7.2 M | |
| Operating Income | -40.9 M | -38.9 M | |
| Income Before Tax | -40.1 M | -38.1 M | |
| Total Other Income Expense Net | 835 K | 876.8 K | |
| Net Loss | -46.5 M | -44.2 M | |
| Income Tax Expense | -2.7 M | -2.5 M | |
| Net Interest Income | 977.5 K | 1 M | |
| Interest Income | 1.1 M | 1.1 M | |
| Net Loss | -33.7 M | -32 M | |
| Net Loss | -6.5 M | -6.9 M | |
| Change To Netincome | 1.3 M | 702.9 K | |
| Net Loss | (1.74) | (1.82) | |
| Income Quality | 0.79 | 0.48 | |
| Net Income Per E B T | 1.33 | 1.27 |
Perspective Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Perspective Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Perspective Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Perspective Therapeutics' important profitability drivers and their relationship over time.
Use Perspective Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Perspective Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perspective Therapeutics will appreciate offsetting losses from the drop in the long position's value.Perspective Therapeutics Pair Trading
Perspective Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Perspective Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Perspective Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Perspective Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Perspective Therapeutics to buy it.
The correlation of Perspective Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Perspective Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Perspective Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Perspective Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Perspective Therapeutics position
In addition to having Perspective Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.